Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the Adequacy of Dialysis

Kidney International

Volumn 55, Issue 4, 1999, Pages 1476-1485

  Jager, Kitty J ^a,b,c   Merkus, Maruschka P ^a,b   Dekker, Friedo W ^a,b   Boeschoten, Els W ^a,b   Tijssen, Jan G P ^a,b   Stevens, Paul ^a,b   Bos, Willem Jan W ^a,b   Krediet, Raymond T ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Netherlands Coop Stud ADF   (Netherlands)

^c NECOSAD Foundation   (Netherlands)

Author keywords

Dialysis technique failure; Fluid overload; Hypertension; Peritoneal ultrafiltration; Systolic blood pressure

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL TRIAL; FEMALE; FLUID BALANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION; URINE VOLUME;

EID: 0032895140     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00353.x     Document Type: Article

References (62)

1. UNITED STATES RENAL DATA SYSTEM: USRDS 1997 Annual Data Report. National Institutes of Health, NIDDK, Bethesda, 1997
2. FOLEY RN, PARFREY PS, HARNETT JD, KENT GM, MARTIN CJ, MURRAY DC, BARRE PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995
3. PARFERY PS, FOLEY RN, HARNETT JD, KENT GM, MURRAY D, BARRE PF: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
4. MAILLOUX LU, NAPOLITANO B, BELLUCI AG, MOSSEY RT, VERNACE MA, WILKES BM: The impact of co-morbid risk factors at the start of dialysis upon the survival of ESRD patients. ASAIO J 42:164-169, 1996
5. KHAN IH, CAMPBELL MK, CANTAROVICH D, CATTO GRD, DELCROIX C, EDWARD N, FONTENAILLE CH, FLEMING LW, GERLAG PGG, VAN HAMERSVELT HW, HENDERSON IS, KOENE RAP, PAPADIMITRIOU M, RITZ E, RUSSELL IT, STIER E, TSAKIRIS D, MACLEOD AM: Survival on renal replacement therapy in Europe: Is there a "centre effect"? Nephrol Dial Transplant 11:300-307, 1996
6. GAMBA G, MEJ́A JL, SALDÍVAR S, PENA JC, CORREA-ROTTER R: Death risk in CAPD patients. Nephron 65:23-27, 1993
7. GENESTIER S, HEDELIN G, SCHAFFER P, FALLER B: Prognostic factors in CAPD patients: A retrospective study of a 10-year period. Nephrol Dial Transplant 10:1905-1911, 1995
8. DAVIES SJ, RUSSELL L, BRYAN J, PHILLIPS L, RUSSELL GI: Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survival. Am J Kidney Dis 26:353-361, 1995
9. CANADA-USA (CANUSA) PERITONEAL DIALYSIS STUDY GROUP: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1996
10. GOKAL R, JAKUBOWSKI C, KING J, HUNT L, BOGLE S, BAILLOD R, MARSH F, OGG C, OLIVER D, WARD M, WILKINSON R: Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicenire study. Lancet 2:1105-1109, 1987
11. SERKES KD, BLAGG CR, NOLPH KD, VONESH EF, SHAPIRO F: Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: A multicenler study. Peril Dial Int 10:15-19, 1990
12. GENTH MA, CARRIAZO A, PAVÓN MI, ROSADO M, CASTILLO D, RAMOS B, ALGARRA GR, TEJIJCA F, BANASCO VP, MILAN JA: Comparison of survival in continuous ambulatory peritoneal dialysis and hospital haemodialysis: A multicentric study. Nephrol Dial Transplant 6:444-451, 1991
13. MAIORCA R, CANCARISI GC, ZUBANI R, CAMERINI C, MANILI L, BRUNORI G, MOVILLI E: CAPD viability: A long-term comparison with hemodialysis. Perit Dial Int 16:276-287, 1996
14. DAVIES SJ, PHILLIPS L, RUSSELL GI: Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 13:962-968, 1998
15. BLAKE PG, FLOWERDEW G, BLAKE RM, OREOPOULOS DG: Serum albumin in patients on Continuous ambulatory peritoneal dialysis: Predictors and correlations with outcomes. J Am Soc Nephrol 3:1501-1507, 1993
16. MAIORCA R, BRUNORI G, ZUBANI R, CANCARINI GC, MANILI L, CAMERINI C, MOVILLI E, POLA A, D'AVOLIO G, GELATTI U: Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: A longitudinal study. Nephrol Dial Transplant 10:2295-2305, 1995
17. NKF-DOQI PERITONEAL DIALYSIS ADEQUACY WORK GROUP: Adequate dose of peritoneal dialysis. Am J Kidney Dis 30(Suppl 2):S86-S92, 1997
18. COLES GA: Have we underestimated the importance of fluid balance for the survival of PD patients? Perit Dial Int 17:321-326, 1997
19. WU CH, HUANG CC, HUANG JY, WU MS, LEU ML: High flux peritoneal membrane is a risk factor in survival of CAPD treatment. Adv Perit Dial 12:105-109, 1996
20. FRIED L: Higher membrane permeability predicts poorer patient survival. Peril Dial Int 17:387-389, 1997
21. WANG T, HEIMBÜRGER O, WANIEWSKI J, BERGSTRÖM J, LINDHOLM B: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 13:1242-1249, 1998
22. CHURCHILL DN, THORPE KE, NOLPH KD, KESHAVIAH PR, OREOPOULOS DG, PAGÉ D, FOR THE CANADA-USA (CANUSA) PERITONEAL DIALYSIS STUDY GROUP: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9:1285-1292, 1998
23. DURNIN JVGA, WOMERSLEY J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97, 1974
24. BERGSTRÖM J, FÜRST P, ALVESTRAND A, LINDHOLM B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44:1048-1057, 1993
25. HARTY JC, BOULTON H, CURWELL, J, HEELIS N, UTTLEY L, VENNING MC, GOKAL R: The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 45:103-109, 1994
26. WATSON PE, WATSON ID, BATT RD, PHIL D: Total body water volumes for adult mates and females estimated from simple anthropometric measurements. Am J Clin Nutr 33:27-39, 1980
27. TWARDOWSKI ZJ, NOLPH KD, KHANNA R, PROWANI BF, RYAN LP, MOORE HL, NIELSEN MP: Peritoneal equilibration test. Perit Dial Bull 7:138-147, 1987
28. KARNOFSKY DA, BURCHENAL JH: The clinical evaluation of chemotherapeutic agents in cancer, in Evaluation of Chemotherapeutic Agents, edited by MCLEOD CM, New York, Columbia University Press, 1949, pp 191-205
29. WARE JE, SNOW KK, KOSINSKI M, GANDEX B: SF-36 Health Surrey Manual and Interpretation Guide. Boston, Health Institute, 1993
30. WARE JE, KOSINSKI M, KELLER SD: SF-36 Physical and Mental Health Summary Scales: A User's Manual (2nd printing, revised). Boston, Health Institute, 1994
31. NAGELKERKE NJD: A note on a general definition of the coefficient of determination. Biometrika 78:691-692, 1991
32. KANNEL WB, WOLF PA, VERTER J, MCNAMARA PM: Epidemiologic assessment of the role of blood pressure in stroke. JAMA 214:301-310, 1970
33. MACMAHON S, PETO R, CUTLER J, COLLINS R, SORLIE P, NEATON J. ABBOTT R, GODWIN J, DYER A, STAMLER J: Blood pressure, stroke, and coronary heart disease. Part 1. prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 335:765-774, 1990
34. O'DONNELL CJ, RIDKER PM, GLYNN RJ, BERGER K, AJANI U, MANSON JAE, HENNEKENS CH: Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 95:1132-1137, 1997
35. WILSON PWF, ANDERSON KM, CASTELLI WP, KANNEL WB: Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: The Framingham offspring study. Am J Med 90:11-16, 1991
36. COLLINS R, PETO R, MACMAHON S, HEBERT P, FIEBACH NH, EBERLEIN KA, GODWIN J, QIZILBASH N, TAYLOR JO, HENNEKENS CH: Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blond pressure: Overview of randomised drug trials in their epidemiological context. Lancet 335:827-838, 1990
37. VOKONAS PS, KANNEL WB, CUPPLES LA: Epidemiology and risk of hypertension in the elderly: The Framingham study. J Hypertens 6(Suppl 1):S3-S9, 1988
38. BENETOS A, SAFAR M, RUDNICHI A, SMULYAN H, RICHARD JL, DUCIMETIÉRE P, GUIZE L: Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population. Hypertension 30:1410-1415, 1997
39. KOSTIS JB, DAVIS BR, CUTLER J, GRIMM RH, BERGE KG, COHEN JD, LACY CR, PERRY HM, BLAUFOX MD, WASSERTHEIL-SMOLLER S, BLACK HR, SCHRON E, BERKSON DM, CURB JD, SMITH WM, MCDONALD R, APPLEGATE WB, FOR THE SHEP COOPERATIVE RESEARCH GROUP: Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 278:212-216, 1997
40. STAESSEN JA, FAGARD R, THIJS L, CELIS H, ARABIDZE GG, BIRK-ENHÄGER WH, BULPITT CJ, DE LEEUW PW, DOLLEKY CT, FLETCHER AE, FORETTE F, LEONETTI G, NACHEV C, O'BRIEN ET, ROSENFELD J, RODICIO JL, TUOMILEHTO J, ZANCHETTI A, FOR THE SYSTOLIC HYPERTERNSION IN EUROPE (SYST-EUR) TRIAL INVESTIGATORS: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350:757-764, 1997
41. FOLEY RN, PARFREY PS, HARNETT JD, KENT GM, MURRAY DC, BARRE PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
42. KEMPERMAN FAW, VAN LEUSEN K, VAN LIEBERGEN FJHM, OOSTING J, BOESCHOTEN EW, STRUIJK DG, KREDIET RT, ARISZ I.: Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy. Neth J Med 38:236-245, 1991
43. RAINE AEG, MARGREITER R, BRUNNER FP, EHRICH JHH, GEERLINGS W, LANDAIS P, LOIRAT C, MALLICK NP, SELWOOD NH, TUFVESON G, VALDERRABANO F: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7(Suppl 2):7-35, 1992
44. LONDON G, GUERIN A, PANNIER B, MARCHAIS S, BENETOS A, SAFAR M: Increased systolic pressure in chronic uremia: Role of arterial wave reflections. Hypertension 20:10-19, 1992
45. LONDON G, MARCHAIS S, GUERIN AP: Blood pressure control in chronic hemodialysis patients, in Replacement of Renal Function by Dialysis (4th ed), edited by JACOBS C, KJELLSTRAND CM, KOCH KM, WINCHESTER JF, Norwell, Kluwer Academic Publishers, 1996
46. MOURAD JJ, GIRERD X, BOUTOUYRIE P, LAURENT S, SAFAR M, LONDON G: Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 30:1425-1430, 1997
47. O'ROURKE MF, KELLY RP: Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens 11:337-337, 1993
48. WESTERHOF N, O'ROURKE MF: Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens 13:943-952, 1995
49. ROTTEMBOURG J: Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 43(Suppl 40):S106-S110, 1993
50. WONG KC, XIONG DW, KERR PG, BOROVNICAR DJ, STROUD DB, ATKINS RC, STRAUSS BJG: Kt/V in CAPD by different estimations of V. Kidney Int 48:563-569, 1995
51. TZAMALOUKAS AH, SADDLER MC, MURATA GH, MALHOTRA D, SENA P, SIMON D, HAWKINS KL, MORGAN K, NEVAREZ M, WOOD B, ELLEDGE L, GIBEL LJ: Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 6:198-206, 1995
52. FRANKLIN SS, GUSTIN W, WONG ND, LARSON MG, WEBER MA, KANNEL WB, LEVY D: Hemodynamic patterns of age-related changes in Wood pressure: The Framingham heart study. Circulation 96:308-315, 1997
53. SARA PS, ROMAN MJ, PINI R, SPITZER M, GANAU A, DEVEREUX RB: Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 22:1873-1880, 1993
54. SILBERBERG JS, BARRE PE, PRICHARD SS, SNIDERMAN AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286-290, 1989
55. KREDIET RT, KOOMEN GCM, STRUIJK DG, VAN OLDEN RW, IMHOLZ ALT, BOESCHOTEN EW: Practical methods for assessing dialysis efficiency during peritoneal dialysis. Kidney Int 46(Suppl 48):S7-S13, 1994
56. RONCO C, CONZ P, AGOSTINI F, BOSCH JP, LEW SQ, LA GRECA G: The concept of adequacy in peritoneal dialysis. Perit Dial Int 14(Suppl 3):S93-S98, 1994
57. HENDERSON LW: Why do we use clearance? Blood Purif 13:283-288, 1995
58. KESHAVIAH PR, NOLPH KD, MOORE HL, PROWANJ B, EMERSON PF, MEYER M, TWARDOWSKI ZJ, KHANNA R, PONFERRADA L, COLLINS A: Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 4:1475-1485, 1994
59. MARCELLI D, STANNARD D, CONTE F, HELD PJ, LOCATELLI F, PORT FK: ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 50:1013-1018, 1996
60. GREENFIELD S, SULLIVAN L, SILLIMAN RA, DUKES K, KAPLAN SH: Principles and practice of case mix adjustment: Applications to end-stage renal disease. Am J Kidney Dis 24:298-307, 1994
61. STRUIJK DG, KREDIET RT, KOOMEN GCM, BOESCHOTEN EW, ARISZ L: The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 14:121-126, 1994
62. ROCCO MV, JORDAN JR, BURKART JM: 24-hour dialysate collection for the determination of peritoneal membrane transport characteristics: Longitudinal follow-up data for the dialysis adequacy and transport test (DATT). Perit Dial Int 16:590-593, 1996